Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody attenuates the aggressiveness of gastric cancer cells
Keyword(s):
Keyword(s):
1991 ◽
Vol 82
(11)
◽
pp. 1258-1262
◽
Keyword(s):
Keyword(s):
2018 ◽
Vol Volume 14
◽
pp. 17-32
◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):